Mabgeek Biotechnology Overview
- Year Founded
-
2016
- Status
-
IPO Registration
- Employees
-
43
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
16
Mabgeek Biotechnology General Information
Description
Developer of a new antibody biotechnology designed to overcome autoimmune diseases. The company focuses on research and development of antibody drugs for allergic inflammatory diseases and autoimmune diseases, enabling patients to receive effective treatment and improve their health conditions.
Contact Information
Website
www.mabgeek.comCorporate Office
- Building 5, No. 34, Lane 122, Chunxiao Road
- Zhangjiang Town, Pudong New District
- Shanghai, 201203
- China
Corporate Office
- Building 5, No. 34, Lane 122, Chunxiao Road
- Zhangjiang Town, Pudong New District
- Shanghai, 201203
- China
Mabgeek Biotechnology Timeline
Mabgeek Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. IPO | 14-Jul-2025 | Announced | Generating Revenue | |||
| 9. Later Stage VC | 11-Jul-2025 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | 05-Jun-2025 | Completed | Clinical Trials - General | |||
| 7. Secondary Transaction - Private | 26-Jul-2024 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC (Series B) | 24-Apr-2024 | Completed | Clinical Trials - General | |||
| 5. Secondary Transaction - Private | 30-Nov-2023 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC | 24-Aug-2021 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series A1) | 09-Apr-2021 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 19-Jan-2019 | $6.8M | $7.96M | Completed | Clinical Trials - General | |
| 1. Seed Round | 17-Feb-2017 | $1.16M | $1.16M | Completed | Startup |
Mabgeek Biotechnology Patents
Mabgeek Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025223497-A1 | Stable formulation of anti-human il-4ra monoclonal antibody | Pending | 26-Apr-2024 |
Mabgeek Biotechnology Signals
Mabgeek Biotechnology Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Zhongshan Financial Investment | Venture Capital | Minority | ||
| GF Qianhe | Venture Capital | Minority | ||
| Guiyang Venture Capital | Growth/Expansion | Minority | ||
| Beijing Jinhui Investment | Growth/Expansion | Minority | ||
| Hunan Guochuang Industrial Investment | Growth/Expansion | Minority |
Mabgeek Biotechnology FAQs
-
When was Mabgeek Biotechnology founded?
Mabgeek Biotechnology was founded in 2016.
-
Where is Mabgeek Biotechnology headquartered?
Mabgeek Biotechnology is headquartered in Shanghai, China.
-
What is the size of Mabgeek Biotechnology?
Mabgeek Biotechnology has 43 total employees.
-
What industry is Mabgeek Biotechnology in?
Mabgeek Biotechnology’s primary industry is Drug Discovery.
-
Is Mabgeek Biotechnology a private or public company?
Mabgeek Biotechnology is a Private company.
-
What is Mabgeek Biotechnology’s current revenue?
The current revenue for Mabgeek Biotechnology is .
-
How much funding has Mabgeek Biotechnology raised over time?
Mabgeek Biotechnology has raised $96.3M.
-
Who are Mabgeek Biotechnology’s investors?
Zhongshan Financial Investment, GF Qianhe, Guiyang Venture Capital, Beijing Jinhui Investment, and Hunan Guochuang Industrial Investment are 5 of 16 investors who have invested in Mabgeek Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process